CAS: 1337531-06-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK2593074A REF: 54-BUP05275CAS: 1337531-06-2 | ≥98% | 1,063.00 €~1,839.00 € | Wed 30 Apr 25 |
 | GSK2593074A REF: 3D-MDC53106CAS: 1337531-06-2 | Min. 95% | To inquire | Tue 10 Jun 25 |
 | GSK2593074A REF: TM-T11484CAS: 1337531-06-2 | 100% | 114.00 €~1,359.00 € | Tue 17 Jun 25 |
Ref: 54-BUP05275
| 25mg | 1,063.00 € | ||
| 50mg | 1,377.00 € | ||
| 100mg | 1,839.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
GSK2593074A
CAS:1337531-06-2
Please enquire for more information about GSK2593074A including the price, delivery time and more detailed …
Formula:
C27H23N5OS
Purity:
Min. 95%
Molecular weight:
465.57 g/mol
Ref: 3D-MDC53106
| 25mg | 1,242.00 € | ||
| 50mg | 1,727.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025
GSK2593074A
CAS:1337531-06-2
GSK2593074A (GSK'074) is a programmed necrosis inhibitor that displays inhibitory effects on RIP1 and RIP3.
Formula:
C27H23N5OS
Purity:
100%
Color and Shape:
Solid
Molecular weight:
465.57
Ref: TM-T11484
| 1mg | 114.00 € | ||
| 5mg | 274.00 € | ||
| 10mg | 432.00 € | ||
| 25mg | 725.00 € | ||
| 50mg | 1,017.00 € | ||
| 100mg | 1,359.00 € | ||
| 1mL*10mM (DMSO) | 303.00 € |
Estimated delivery in United States, on Tuesday 17 Jun 2025
